health-radio-header

Health Topics A-Z

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Z

Vaginal Estrogen & the New Labeling

From the Show: Health Radio
Summary: Deciphering labels can be tricky. That's why it's important to know all the facts before taking any medication.
Air Date: 12/2/15
Duration: 10
Host: Melanie Cole, MS
Guest Bio: Diana Bitner, MD
Diana BitnerDiana Bitner, MD, is board certified in obstetrics and gynecology and a certified menopause practitioner. She received her medical degree from Wayne State University School of Medicine in Detroit and completed her residency in obstetrics and gynecology at Butterworth Hospital in Grand Rapids, Michigan. She is a member of the Spectrum Health Medical Group.

Dr. Bitner has special interests in women's wellness and prevention of heart disease, menopause, perimenopause, laparoscopic and robotic pelvic surgery, and pelvic pain. She enjoys helping women through times of health concerns and life phase transitions with an integrated and evidence-based approach. Her professional goal is to help women be as healthy as they want to be. She is also fluent in Portuguese.

Dr. Bitner has a weekly media engagement with WXMI Fox 17 Morning Mix discussing health topics of importance to women. She regularly engages in media and online chats and authors a blog, titled Midlife & Menopause Moments, which can be found on Health Beat, Spectrum Health's e-news website.
Vaginal Estrogen & the New Labeling
Recently, many leaders in women's heath addressed with the FDA the black box warning on vaginal estrogen.

Vulvovaginal atrophy (VVA) is when your vaginal walls become inflamed, dry, and thin due to your body having less estrogen.

VVA causes significant medical issues for most women in menopause, including dryness, pain with intercourse, and bladder urgency.

It can contribute to pelvic prolapse and subsequent difficulty emptying the bladder and/or rectum, as well as incontinence.

Women deserve treatment options, and for many, vaginal estrogen provides a safe and effective option. The current FDA black box class warning causes confusion and undue concern by patients or health care providers reading the label.

Listen in as Diana Bitner, MD, discusses VVA and the important new labeling you need to know about vaginal estrogen.
FREE RadioMD Newsletter:
{JFBCFan height=395 width=350 colorscheme=light href=http://www.facebook.com/YourRadioMD show_faces=1 stream=0 header=1 border_color=#C8C8C8 force_wall=0 key=rmd123}